A population-based study from Hong Kong showed that the PNPLA3 polymorphism remained an independent risk factor for non-obese NAFLD after adjusting for other metabolic covariates (34). This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.